$6.470
0.000 (0.00%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
Should I Buy Sinovac Biotech Ltd Stock?
Sinovac Biotech Ltd is currently not a strong buy due to its negative financial metrics, including a forward P/E ratio of 357.14, indicating high valuation concerns. While the company has declared a special cash dividend of $55 per share, which could enhance shareholder confidence, the overall financial performance shows significant risks, particularly with a negative price-to-earnings ratio of -1.87. The main risk is the high forward P/E ratio, suggesting that the stock may be overvalued at its current price.
SVA stock price ended at $6.47 on Friday, after rising 0.00%
Sinovac Biotech Ltd (SVA) last closed at $6.47, gaining +0.00%. These facts feed the 1-day and 1-week SVA price prediction above.
Forecast Drivers
Sinovac Biotech Ltd (SVA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Seasonality analysis for SVA
Historically the probability of a positive August return for SVA is 0.00%. January offers the highest probability of a positive month at 0.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.